When Stopping Is the Smartest Move: How DCN Dx Helped an IVD Company Avoid Further Risk

dcn_landing-page_image_case-study-established-diagnostic-01_20250331.jpg

A Case Study on Transparent Assessment, Honest Feedback, and Saving Time and Budget

This case study follows an established IVD company that transferred a lagging diagnostic program to DCN Dx after losing confidence in their previous CDMO. The assay wasn’t performing to spec. Budget and timeline pressures were mounting. And despite significant investment, the path forward was unclear.

DCN Dx performed a detailed assessment, reproduced prototypes, and ran targeted experiments that confirmed what the client suspected: the design would require a full overhaul. That overhaul wasn’t feasible within the client’s constraints—and DCN Dx didn’t sugarcoat it. Instead, they delivered clear, honest feedback that allowed the client to make a well-informed decision to halt development.

This kind of transparent evaluation saved the client from continued spend on a project that wouldn’t meet their needs—while preserving the relationship for future programs.

WHY READ

This case study is for teams weighing the viability of a stalled or underperforming program. Learn how DCN Dx:

  • Identified core design issues early, avoiding more wasted investment.
  • Delivered technical validation that confirmed a full redesign would be required.
  • Helped a client make a difficult but informed decision to discontinue the program.
  • Provided transparent, value-driven feedback without overpromising.
  • Preserved trust and partnership for future collaboration.

READ IT NOW

Subscribe to the DCN Dx Newsletter

Get in touch

3193 Lionshead Ave
Suite 200
Carlsbad, CA 92010
USA

No products in the cart.

[biospecimens_menu_source]